[Ballistic quality assurance].

Fiche publication


Date publication

juin 2012

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier


Tous les auteurs :
Cassol E, Bonnet J, Porcheron D, Mazeron JJ, Peiffert D, Alapetite C

Résumé

This review describes the ballistic quality assurance for stereotactic intracranial irradiation treatments delivered with Gamma Knife(R) either dedicated or adapted medical linear accelerators. Specific and periodic controls should be performed in order to check the mechanical stability for both irradiation and collimation systems. If this step remains under the responsibility of the medical physicist, it should be done in agreement with the manufacturer's technical support. At this time, there are no recent published guidelines. With technological developments, both frequency and accuracy should be assessed in each institution according to the treatment mode: single versus hypofractionnated dose, circular collimator versus micro-multileaf collimators. In addition, "end-to-end" techniques are mandatory to find the origin of potential discrepancies and to estimate the global ballistic accuracy of the delivered treatment. Indeed, they include frames, non-invasive immobilization devices, localizers, multimodal imaging for delineation and in-room positioning imaging systems. The final precision that could be reasonably achieved is more or less 1mm.

Référence

Cancer Radiother. 2012 Jun;16 Suppl:S30-7